Rafferty Asset Management, LLC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 166 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Rafferty Asset Management, LLC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5,966,985
-37.9%
510,435
-28.6%
0.04%
-35.2%
Q2 2023$9,607,920
+24.7%
714,875
+53.8%
0.05%
+3.8%
Q1 2023$7,704,179
-15.9%
464,667
-5.6%
0.05%
-32.5%
Q4 2022$9,159,589
+76.4%
492,451
+21.7%
0.08%
+40.0%
Q3 2022$5,192,000
+297.9%
404,709
+117.5%
0.06%
+358.3%
Q2 2022$1,305,000
-32.0%
186,100
-19.6%
0.01%
+9.1%
Q1 2022$1,919,000
+24.0%
231,508
+1.3%
0.01%
+37.5%
Q4 2021$1,548,000
+51.5%
228,588
+18.6%
0.01%
+14.3%
Q3 2021$1,022,000
-7.5%
192,786
+0.3%
0.01%0.0%
Q2 2021$1,105,000
-45.0%
192,192
-55.9%
0.01%
-50.0%
Q1 2021$2,009,000
+894.6%
435,824
+619.3%
0.01%
+600.0%
Q4 2020$202,000
-70.9%
60,586
-74.0%
0.00%
-75.0%
Q3 2020$693,000
+76.8%
233,330
+174.8%
0.01%
+33.3%
Q2 2020$392,000
+199.2%
84,901
+149.4%
0.01%
+20.0%
Q1 2020$131,000
-90.4%
34,048
-90.6%
0.01%
-76.2%
Q4 2019$1,359,000
+51.0%
362,296
+113.8%
0.02%
+50.0%
Q3 2019$900,000169,4180.01%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 589,883$590,0001.38%
Broadfin Capital, LLC 8,200,000$8,610,0000.96%
Avoro Capital Advisors LLC 1,141,149$1,198,0000.24%
CORRADO ADVISORS, LLC 190,600$200,0000.12%
Baker Brothers Advisors 5,102,153$5,357,0000.05%
KINGDON CAPITAL MANAGEMENT, L.L.C. 756,311$794,0000.04%
Point72 Asset Management, L.P. 2,272,816$2,386,0000.02%
AGRAN LIBBIE 44,000$46,0000.01%
COMPTON CAPITAL MANAGEMENT INC /RI 10,000$11,0000.01%
KENNEDY CAPITAL MANAGEMENT LLC 233,171$245,0000.00%
View complete list of CATALYST PHARMACEUTICALS INC shareholders